Archive

Blume Equity secures €25m funding from British Patient Capital for first fund

British Patient Capital invests £30m in Northern Gritstone

Biotech impact fund achieves $265m first close

An 'impact medicine fund' targeting investments in novel treatments for diseases that have until now been underserved has raised $265 million at first close.